Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study.

Fumihiro ShojiTakanori YamashitaFumihiko KinoshitaShinkichi TakamoriTakatoshi FujishitaRyo ToyozawaKensaku ItoKoji YamazakiNaoki NakashimaTatsuro Okamoto

Published in: BMJ open (2022)

UMIN000046428.

Keyphrases

artificial intelligence
machine learning
big data
deep learning
randomized controlled trial
study protocol
clinical trial
double blind
cross sectional